LIN PATRICK (Chief Business - Strategy Off) purchased 19.1% of their position (2.11K shares) of PROCESSA PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $4.1K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/1/2026ACC: 0000897069-26-001482
Officer· Chief Business - Strategy Off
Since Oct 2020
+2.11K
Net shares
Net buyer
$4.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.11K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.11K
Price / share
$1.93
Trade value
$4.06K
% of position
19.1%
6/30/2026
11.01K→13.11K
Total
Net shares
+2.11K
Net value
$4.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2026 | P · Purchase | +2.11K | $1.93 | $4.06K | 19.1% | 11.01K | 13.11K |
| Total | +2.11K | $4.06K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.74K
Total
1.74K indirect1.74K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.74K | Indirect |
| Total | 1.74K | 1.74K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported